Objective: HLA-B*40:247 is a low incidence allele in the HLA-B locus. The aim of this study is to confirm the ethnicity of B*40:247 and its deduced probable HLA-associated haplotype in Taiwanese individuals. Materials and Methods: A total of 2,329 unrelated Taiwanese individuals and 66,212 unrelated mainland Chinese individuals were tested for HLA using a sequence-based typing method. We confirmed the low incidence allele B*40:247 in Taiwanese. Polymerase chain reaction was performed to amplify exons 2, 3 and 4 of the HLA-A and HLA-B loci and exon 2 of the HLA-DRB1 locus using groupspecific primer sets. The amplicons were sequenced in both directions with the *BigDye Terminator Cycle Sequencing Ready Reaction Kit according to the manufacturer's protocols. Results: The DNA sequence of B*40:247 is identical to B*40:01:01 in exons 2, 3 and 4 except for residue 853, where G of B*40:01:01 is changed to A in B*40:247 (codon 261, GTA->ATA). The nucleotide replacement causes a one amino acid change at codon 261 where V (valine) of B*40:01:01 is replaced by I (isoleucine) in B*40:247. We deduced the probable HLA haplotype associated with B*40:247 in Taiwanese to be HLA-A*24:02-B*40:247-C*03:04-DRB1*16:02. Conclusion: Information on the ethnicity and distribution of B*40:247 and its deduced probable HLA haplotype in association with the low incidence allele is of value for HLA testing laboratories for reference purposes and can help bone marrow donor registries find compatible donors for patients with this uncommon HLA allele.
Introduction
N ew human leukocyte antigen (HLA) alleles continue to be discovered, and the recognition of HLA low-incidence alleles has enriched our understanding of the complexity of the HLA system. The HLA genes are characterized by their extreme allelic polymorphism as well as their variations and diversity in different ethnic groups and racial populations. The genes encoding the HLA alleles are located in the major histocompatibility complex Class I and II regions. HLA molecules have been definitely defined as transplant antigens and have a strong relevance to tissue transplantation. Their molecular similarity in donors and recipients is being considered a predictive factor for graft survival and graft versus host disease [1] . It is imperative to precisely characterize any unknown and low-incidence alleles encountered during routine HLA typing This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com on the B*40:247-associated HLA haplotype and ethnic origin of the source individual [2] . In this report, we confirm the ethnicity of B*40:247 and identify the deduced plausible HLA haplotype in association with B*40:247 based on the HLA typing of Taiwanese individuals and the donor submitted to the IMGT/HLA database [2] .
Materials and methods
A total of 2329 unrelated Taiwanese individuals and 66,212 unrelated mainland Chinese participants were tested for B*40:247 in this study. Peripheral whole blood samples from donors with Taiwanese ethnicity and individuals with mainland Chinese ethnicity were collected in acid citrate dextrose (ACD) anticoagulant. Formal written consent was signed by the donors before blood collection. The ACD whole blood samples were stored at −80ºC until use. Genomic DNA was extracted using the QIAamp DNA Blood Mini kit according to the manufacturer's instructions (Qiagen, Hilden, Germany). The DNA material was subjected to HLA genotyping for the HLA-A, HLA-B, HLA-C, and HLA-DRB1 loci using a commercial polymerase chain reaction-sequencing-based typing kit (TBG, Medigen Biotechnology, Taipei, Taiwan). The amplicons were sequenced in both directions with the *BigDye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's protocols.
Results
In a total of 2329 randomized unrelated Taiwanese 
Discussion
We confirmed the DNA sequence and amino acid sequence of the low-frequency allele HLA-B*40:247 [2] . The DNA sequence of B*40:247 is identical to B*40:01:01 in exons 2, 3, and 4 except for a one nucleotide substitution at residue 853. The nucleotide substitution results in a one amino acid replacement at amino acid position 261 in B*40:247. Whether the mutation of B*40:247 in exon 4 has any impact on antigen presentation, and immune regulation functions of its protein molecule are unclear. This warrants the future study. B*40:247 was initially discovered in a Taiwanese individual (Genbank Accession Number KF208638; IMGT/HLA Database HWS10018882) [2] without knowledge of the probable HLA haplotype in association with the allele. In this study, we ascertained the ethnicity of B*40:247 and proposed the deduced probable B*40:247-associated HLA haplotype to be A*24:02-B*40:247-C*03:04-DRB1*16:02 based on the HLA-A, HLA-B, HLA-C, and HLA-DRB1 alleles shared in common by our randomized unrelated donors and the donor reported to the IMGT/HLA Database [ Table 1 ]. Although we found two Hakka Taiwanese individuals carrying B*40:247, we cannot be certain B*40:247 is restricted to Hakka Taiwanese, pending further investigation. Nevertheless, we propose that the deduced probable B*40:247-associated HLA haplotype is most likely restricted to Taiwanese since B*40:247 has only been found in the Taiwanese population but not in the mainland Chinese population. Furthermore, our search on the Allele Frequency Net (http://www.allelefrequencies.net) failed to find B*40:247 in other populations. In addition, the lack of B*40:247 in the mainland Chinese population is supported by Zhou et al. [4] , who found no individual with B*40:247 in a total of 169,995 volunteer donors tested from the China Bone Marrow Donor Registry Program. Information on the ethnicity of B*40:247 and its linked HLA haplotype can be employed in the anthropological investigation of races. In addition, bone marrow donor registries can allocate appropriate unrelated stem cell donors for patients with B*40:247. In addition, knowing the It is worth mentioning that the most direct and classic method of determining HLA haplotypes is through a family study if test materials from a number of key family members are available. Alternatively, a population study may be employed if a sufficient number of unrelated donors are available [5] . However, the haplotypes deduced through population investigation are considered to be likely or most probable. In this study, because of the lack of availability of necessary test materials from the families of the individuals with B*40:247, we opted to determine the haplotypes by looking at the HLA alleles carried in common by unrelated donors with the same alleles of interest. By the same token, if determination of plausible HLA-associated haplotypes is for rare or low-frequency HLA alleles, the alleles shared in common by unrelated individuals may be employed to deduce the associated probable haplotypes [6] [7] [8] [9] [10] [11] [12] [13] . The frequency of B*40:247 in Taiwanese is extremely low at approximately 0.086%. Therefore, we think that the deduced probable B*40:247-associated HLA haplotype in Taiwanese in this study is accurate.
The number of known HLA alleles is increasing with the recent development of DNA-based molecular typing technology. There is a high level of HLA diversity among ethnic groups and knowledge of this diversity is important. Matching of bone marrow stem cell donors relies on the accuracy of HLA typing results. This is dependent on the resolution of unknown, ambiguous, and low-incidence genes in the HLA system.
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